Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myeloma
Closed
Phase 3
This trial is looking at treating newly diagnosed solitary bone plasmacytoma with lenalidomide and dexamethasone after having radiotherapy. Cancer Research UK supports this trial.
Recruitment start: 10 March 2017
Recruitment end: 27 October 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Roger Owen
Cancer Research UK
Celgene Ltd
University College London (UCL)
This is Cancer Research UK trial number CRUK/14/032.
Last reviewed: 28 Oct 2020
CRUK internal database number: 12865
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
